Sentences with phrase «for early prostate cancer»

Study Discounts Testosterone Therapy for Early Prostate Cancer New York Times, NYTimes.com — July 14, 2014

Not exact matches

Blackmun stepped down earlier this week to deal with prostate cancer, though Raisman, several high - profile gymnasts and two U.S. Senators had been calling for his ouster for weeks.

NEW YORK (360Dx)-- Biotech firm Berg continued its push into cancer diagnostics with the presentation of several posters earlier this month at the annual meeting of the American Association for Cancer Research and the preparation of a forthcoming publication detailing an assay for distinguishing between prostate cancer and benign prostate hyperpcancer diagnostics with the presentation of several posters earlier this month at the annual meeting of the American Association for Cancer Research and the preparation of a forthcoming publication detailing an assay for distinguishing between prostate cancer and benign prostate hyperpCancer Research and the preparation of a forthcoming publication detailing an assay for distinguishing between prostate cancer and benign prostate hyperpcancer and benign prostate hyperplasia.

It has high hopes for approvals of earlier use of Ibrance and the prostate cancer drug Xtandi that would boost sales.

A new screening tool for prostate cancer, the prostate - specific antigen test, enabled doctors to detect it earlier in more men, and patients were flocking to hospitals for low doses of conventional photon radiation.

Several markers for dying from prostate cancer exist, but whether these are markers for telling who is likely to die early from any cause, and how their performance compares, is unknown.

«An estimated 220,000 men are expected to be newly diagnosed with prostate cancer each year in the United States, and the majority will have early - stage disease at low risk for recurrence,» Lee said.

«This study's results can have practice changing implications on how future prostate cancer trials are designed in terms of identifying the men for these studies who are at high risk for early death due to ineffective initial treatment for their prostate cancer,» stated Anthony Victor D'Amico, MD, PhD, chief, Genitourinary Radiation Oncology, Brigham and Women's Hospital and senior author of the study.

For prostate cancer patients who have rising levels of PSA (a cancer indicator) even after radical prostatectomy, early treatment makes a difference.

Over the past year, some regional insurers have begun to concur, refusing to pick up the tab for early treatment of prostate cancer.

«With further validation, this radiotracer could also potentially be used to perform targeted biopsies for precise tissue analysis, which could lead to earlier, more appropriate treatment for prostate cancer patients.»

Prostate cancer is highly curable, with a 94 percent 15 - year relative survival rate for early stages.

For patients with early - stage cancer, this option avoids many of the side effects associated with removing the prostate or irradiating the entire gland.

For prostate cancer, the key reason for the fall in death rates is improved management and treatment, with a possible role played by screening and early diagnosFor prostate cancer, the key reason for the fall in death rates is improved management and treatment, with a possible role played by screening and early diagnosfor the fall in death rates is improved management and treatment, with a possible role played by screening and early diagnosis.

For the study, UNC Lineberger researchers surveyed 1,141 men who were diagnosed with early - stage prostate cancer between January 2011 and June 2013.

Cancer Research UK's hunt for finding early stages of aggressive prostate cancer is notCancer Research UK's hunt for finding early stages of aggressive prostate cancer is notcancer is not over.

In 2009 the nongovernmental Institute of Medicine (IOM) released a list of 100 disorders, including lower back pain, atrial fibrillation, and early prostate cancer, that it says require research analyzing which treatments work best for different groups of patients.

Earlier today, the U.S. Food and Drug Administration announced that it was giving the green light to Provenge, a treatment for advanced prostate cancer that has spread to other parts of the body.

«New early detection test for prostate cancer.»

The five types of cancers analyzed in this study have screening methods that allow for detection at an early stage, though in some instances, debate remains over efficacy and appropriate use: mammography for breast cancer, colonoscopy for colorectal cancer, Pap smear and / or HPV test for cervical cancer, spiral computed tomography or CT for lung cancer, and PSA test for prostate cancer.

«The androgen signaling cascade is important for understanding early and late - stage prostate cancer progression.

«Less prostate cancer screening may delay treatment for earlier onset cancers: More advanced cancers are being found in fewer needle biopsies, say investigators.»

«New three - in - one blood test opens door to precision medicine for prostate cancer: Test picks out men for treatment, detects early signs of resistance and monitors cancer's evolution over time.»

This assessment may represent a powerful biomarker to predict cancer progression for men with early - stage prostate cancer.

It could in future allow the PARP inhibitor olaparib to become a standard treatment for advanced prostate cancer, by targeting the drug at the men most likely to benefit, picking up early signs that it might not be working, and monitoring for the later development of resistance.

The study suggests that efforts are needed to reduce racial disparities in prostate cancer care in order to provide earlier treatment for African Americans.

This suggests that Ga - 68 PSMA PET / CT will be an effective imaging tool for early detection of prostate cancer recurrence.

«Early MRI may lower costs for prostate cancer treatment: Study finds MRI and MRI - guided biopsy cheaper long - term than standard ultrasound.»

These guidelines affirm early identification, treatment, and ongoing assessment for psychological distress as important aspects of prostate cancer survivorship care.

«The use of matched patient - derived cells provides a unique model for studies of early prostate cancer.»

«There is a tremendous unmet clinical need for better non-invasive screening tools for early detection of prostate cancer to reduce the overtreatment and morbidity of this disease,» added Dr. Patel.

Published in Urology in April 2007 by Johns Hopkins University researcher Robert Getzenberg and his team, the paper reported that a novel protein in blood could be used as a sensitive test for detecting early prostate cancer.

Similarly, a prostate - specific antigen (PSA) test has revolutionised early diagnosis for this cancer in the US.

Prostate cancer, for example, which is commonly diagnosed at age 66, according to the American Cancer Society, tends to be a cancer most men live with rather than die from, Kruse said, unless it occurs cancer, for example, which is commonly diagnosed at age 66, according to the American Cancer Society, tends to be a cancer most men live with rather than die from, Kruse said, unless it occurs Cancer Society, tends to be a cancer most men live with rather than die from, Kruse said, unless it occurs cancer most men live with rather than die from, Kruse said, unless it occurs early.

Common Treatment for Prostate Cancer Ineffective for Early - Stage Cases, Rutgers Study Finds WHYY (NPR) Radio, Newsworks.org — July 16, 2014

The paper, «MR Imaging - guided Focal Laser Ablation for Prostate Cancer: Phase I Trial,» appears as an early release in Radiology.

Several additional phase 3 trials of apalutamide are currently underway for other prostate cancer disease states, including studies of both earlier and later stage disease.

AMACR gene identified by Kimmel Cancer Center researchers as a prevention and early diagnostic marker for prostate cCancer Center researchers as a prevention and early diagnostic marker for prostate cancercancer.

While accounting for only a small fraction of all prostate cancer cases, the discovery may provide important clues about how this common cancer develops and help to identify a subset of men who might benefit from additional or earlier screening.

Roswell Park and the Buffalo Sabres are teaming up to offer free prostate cancer early detection for eligible men.

Age 40 for men at even higher risk (those with more than one first - degree relative who had prostate cancer at an early age).

THURSDAY, Aug. 18, 2016 (HealthDay News)-- Diagnoses of early prostate cancer continue to decline in the United States, following the U.S. Preventive Services Task Force recommendation against routine screening for the disease, researchers report.

Tell your doctor if a family member has had breast cancer (or even ovarian, prostate, or pancreatic cancers), so you can consider getting screened earlier, and discuss whether genetic testing or preventive medication might be good ideas for you.

As early as 1966, a study found an inverse relationship between tumor volume and the testosterone: DHT ratio in men screened for prostate cancer.

Though I retired from active practice nine years ago, six of my former patients with early prostate cancer have been using progesterone cream (along with diet, some vitamin and mineral supplements, and saw palmetto) for more than five years and report their cancer has shown no progression.

Dr. Dean Ornish showed that a plant - based diet and lifestyle program could apparently reverse the progression of prostate cancer, but that was for early stage, localized, watch - and - wait cancer.

Early treatment of hormone imbalance will significantly decrease the risk of developing breast or prostate cancer for many individuals.

Dr. Dean Ornish revolutionized medicine by directing clinical research proving — for the first time — that heart disease and early - stage prostate cancer may be stopped or even reversed by his program of comprehensive lifestyle changes, without drugs or surgery.

For five years, the researchers followed 35 men with localized, early - stage prostate cancer to explore the relationship between comprehensive lifestyle changes, and telomere length and telomerase activity.

Although most agencies providing recommendations on prostate cancer screening, especially those outside the United States, do not recommend routine PSA testing for the early detection of prostate cancer, it continues to be performed frequently medical experts noted.